Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

The new JNM Supplement is online now – “Molecular Imaging of Neurodegeneration: The Way to New Horizons”

  • Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into Pulmonary Fibrosis Progression
  • Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
  • 18F-FDG PET/CT in the Management of Osteosarcoma
  • Future Directions in Molecular Imaging of Neurodegenerative Disorders
  • 1
  • 2
  • 3
  • 4

Published Ahead of Print

  • Metformin-Induced Receptor Turnover Alters Antibody Accumulation in HER-Expressing Tumors
    You have access
    Metformin-Induced Receptor Turnover Alters Antibody Accumulation in HER-Expressing Tumors
    Sandeep Surendra Panikar, Nai Keltee, Na-Keysha Berry, Shayla Shmuel, Zachary T. Fisher, Emma Brown, Abbey Zidel, Alex Mabry and Patrícia M.R. Pereira
    Journal of Nuclear Medicine June 2, 2023, jnumed.122.265248; DOI: https://doi.org/10.2967/jnumed.122.265248
  • Initial Evaluation of [<sup>18</sup>F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
    Open Access
    Initial Evaluation of [18F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
    Tadashi Watabe, Sadahiro Naka, Mitsuaki Tatsumi, Takashi Kamiya, Toru Kimura, Yasushi Shintani, Kaori Abe, Tomohiro Miyake, Kenzo Shimazu, Shogo Kobayashi, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hidenori Inohara, Hiroki Kato, Yuriko Mori, Jens Cardinale and Frederik L. Giesel
    Journal of Nuclear Medicine June 2, 2023, jnumed.123.265486; DOI: https://doi.org/10.2967/jnumed.123.265486
  • You have access
    MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals
    Lukas M. Carter, Juan C. Ocampo Ramos, Edmond A. Olguin, Justin L. Brown, Daniel Lafontaine, Derek W. Jokisch, Wesley E. Bolch and Adam L. Kesner
    Journal of Nuclear Medicine June 2, 2023, jnumed.122.264230; DOI: https://doi.org/10.2967/jnumed.122.264230
  • Optimized SPECT Imaging of <sup>224</sup>Ra α-Particle Therapy by <sup>212</sup>Pb Photon Emissions
    Open Access
    Optimized SPECT Imaging of 224Ra α-Particle Therapy by 212Pb Photon Emissions
    Lars Tore Gyland Mikalsen, Monika Kvassheim and Caroline Stokke
    Journal of Nuclear Medicine June 2, 2023, jnumed.122.264455; DOI: https://doi.org/10.2967/jnumed.122.264455
  • You have access
    MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
    Adam L. Kesner, Lukas M. Carter, Juan C. Ocampo Ramos, Daniel Lafontaine, Edmond A. Olguin, Justin L. Brown, Bonnie President, Derek W. Jokisch, Darrell R. Fisher and Wesley E. Bolch
    Journal of Nuclear Medicine June 2, 2023, jnumed.122.264225; DOI: https://doi.org/10.2967/jnumed.122.264225
  • You have access
    Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions
    Manish Ora, Neetu Soni, Aftab Hasan Nazar, Manish Dixit, Rohit Singh, Savita Puri, Michael M. Graham and Sanjay Gambhir
    Journal of Nuclear Medicine June 2, 2023, jnumed.123.265594; DOI: https://doi.org/10.2967/jnumed.123.265594
View more published ahead of print articles

Featured Articles

  • Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into...
    June 01, 2023
  • Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
    June 01, 2023
  • 18F-FDG PET/CT in the Management of Osteosarcoma
    June 01, 2023
  • 18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for...
    June 01, 2023
  • Artificial Intelligence Algorithms Need to Be Explainable—or Do They?
    June 01, 2023
  • Theranostic Radiopharmaceuticals: A Universal Challenging Educational Paradigm in Nuclear Medicine
    June 01, 2023
  • Defining Myeloma and Advancing Treatment Options
    June 01, 2023

About The Journal of Nuclear Medicine

The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), a nonprofit, international scientific and professional organization—offers readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.

Current issue

Journal of Nuclear Medicine: 64 (6)
Journal of Nuclear Medicine
Vol. 64, Issue 6
June 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Radiolabeled GPVI-Fc for PET Imaging of Multiple Extracellular Matrix Fibers: A New Look into Pulmonary Fibrosis Progression
  • Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
  • Most Cited
  • Most Read
Loading
  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
  • Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
  • Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review
  • Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
  • Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
More...
Back to top
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire